retatrutide creator I’m Dr. Michael Richman, a double board certified cardiothoracic surgeon. In today’s video, I explain all about the novel peptide which is currently in phase 3 trials for multiple Eli Lilly CEO: Retatrutide will
Description
The standards of diabetes care continue to be reviewed and updated each year
Retatrutide is an experimental weight loss medication currently under clinical evaluation
Pfizer will be pursuing the use of #GLP-1 drugs with amylin analogs, others will look to other therapeutic agents, such as those targeting #INHBE and #GPR75
Consequently, patients are left with the burden of out-of-pocket expenses that can surpass $1,000 monthly
Whether 50-200mg weekly produces any CNS effects is doubtful from a pharmacological perspective
